News

ShangPharma has announced its plans to establish a subsidiary in the Qidong Biopharma Industrial Zone as part of a multistage expansion project for its biologics service portfolio.

Nanoparticles wrapped inside human platelet membranes serve as new vehicles for targeted drug delivery.

Project will identify new potential therapeutics for Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.

UW Medicine among 7 programs in U.S. to test circulatory device on transport between donors and recipients.

The terms of the license cover commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line, developed by Horizon and adapted to manufacturing conditions by LakePharma.

Acquisition will combine two of the world’s leading brands in laboratory consumables.

Recent data suggest that epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs.

Instant, online access to regulatory and technical information on portfolio of 400 products.

The two companies are set to work on the discovery, development and commercialization of novel small molecule therapeutics in oncology, inflammation and immunology, including the rapidly evolving field of immunooncology.

This move strengthens Amgen's cardiovascular portfolio with late-stage, oral CETP inhibitor.